azathioprine has been researched along with Tumor Lysis Syndrome in 1 studies
Azathioprine: An immunosuppressive agent used in combination with cyclophosphamide and hydroxychloroquine in the treatment of rheumatoid arthritis. According to the Fourth Annual Report on Carcinogens (NTP 85-002, 1985), this substance has been listed as a known carcinogen. (Merck Index, 11th ed)
azathioprine : A thiopurine that is 6-mercaptopurine in which the mercapto hydrogen is replaced by a 1-methyl-4-nitroimidazol-5-yl group. It is a prodrug for mercaptopurine and is used as an immunosuppressant, prescribed for the treatment of inflammatory conditions and after organ transplantation and also for treatment of Crohn's didease and MS.
Tumor Lysis Syndrome: A syndrome resulting from cytotoxic therapy, occurring generally in aggressive, rapidly proliferating lymphoproliferative disorders. It is characterized by combinations of hyperuricemia, lactic acidosis, hyperkalemia, hyperphosphatemia and hypocalcemia.
| Excerpt | Relevance | Reference |
|---|---|---|
| "His tacrolimus dosage was decreased, and azathioprine was discontinued." | 1.33 | Tumor lysis syndrome associated with reduced immunosuppression in a lung transplant recipient. ( Deel, C; Hellman, RN; Khan, BA, 2006) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Khan, BA | 1 |
| Deel, C | 1 |
| Hellman, RN | 1 |
1 other study available for azathioprine and Tumor Lysis Syndrome
| Article | Year |
|---|---|
Tumor lysis syndrome associated with reduced immunosuppression in a lung transplant recipient.
Topics: Aged; Azathioprine; Fatal Outcome; Humans; Immunosuppressive Agents; Liver Transplantation; Lymphopr | 2006 |